Welcome to our dedicated page for PetMed Express news (Ticker: PETS), a resource for investors and traders seeking the latest updates and insights on PetMed Express stock.
PetMed Express, Inc. (NASDAQ: PETS), widely recognized as PetMeds, is America's largest pet pharmacy. Established in 1996, PetMeds provides both prescription and non-prescription pet medications, health products, and nutritional supplements for dogs, cats, and horses directly to consumers at substantial savings. The company operates from a single location, delivering exceptional value and convenience to millions of satisfied customers nationwide.
PetMeds generates revenue primarily by selling pet medications and supplies, targeting retail consumers. The company prides itself on being a trusted pet health expert, offering competitive prices and convenient access to a wide range of products. Pet parents can purchase these products through PetMeds' toll-free number (1-800-PetMeds) or online at www.petmeds.com.
Recently, PetMeds partnered with Hill's Pet Nutrition to offer Hill's Science Diet products on PetMeds' platform starting March 1, 2024. To celebrate this partnership, PetMeds launched a promotional giveaway, providing a year's worth of Hill's Science Diet to one lucky winner. This initiative aligns with PetMeds' commitment to responsible pet ownership and support for animal shelters facing capacity crises.
PetMeds also offers innovative services like Pumpkin® pet insurance plans and same-day VetLive® telehealth appointments, making veterinary care more accessible and affordable. Furthermore, through its wholly-owned subsidiary, PetCareRx, PetMeds extends its reach by providing additional pet health products and services.
The company's financial stability is underscored by its consistent performance and strategic partnerships. PetMeds is scheduled to host a conference call on February 8, 2024, to discuss its third-quarter results, followed by a Q&A session. This event provides an opportunity for investors and stakeholders to gain insights into the company's operations and future plans.
For more information, visit www.petmeds.com or contact PetMeds' investor relations team at investor@petmeds.com.
PetMeds (NASDAQ: PETS) has announced the adoption of a duration shareholder rights plan to protect shareholders' interests. The plan, effective immediately until December 2, 2025, was implemented in response to recent significant stock accumulations and concerns that shares don't reflect the company's inherent value. Under the plan, shareholders will receive one right per common stock share as of December 16, 2024. These rights become exercisable if an entity acquires 12.5% or more of outstanding shares without Board approval, allowing other shareholders to purchase additional shares at a 50% discount to market price.
PetMed Express (NASDAQ: PETS) has partnered with Ordergroove to enhance its subscription and membership capabilities. The collaboration aims to modernize PETS' Autoship program by implementing advanced platform features including prepaid subscriptions, self-service management, and personalized promotions. The partnership integrates product catalogs from both PetMeds and PetCareRx, creating a unified subscription membership experience. CEO Sandra Campos emphasized that this strategic move will support innovation while increasing customer satisfaction and retention. The implementation is expected to expand PETS' subscriber base and improve service accessibility while enabling faster market innovations.
PetMed Express, Inc., operating as PetMeds and parent company of PetCareRx (Nasdaq: PETS), will participate in the Sidoti Micro Cap Conference on November 13-14, 2024. The event will be held virtually. Sandra Campos, CEO and President, will present to investors at approximately 1:45 p.m. Eastern Time on Wednesday, November 13, 2024. A live webcast of the presentation will be available on the “Events & Presentations” section of PetMed’s investor relations website at https://investors.petmeds.com.
PetMed Express (NASDAQ: PETS) reported its Q2 fiscal 2025 financial results with net sales of $59.6 million and a gross margin of 29.1%, up 0.8% year-over-year. The company posted net income of $2.3 million, or $0.11 per diluted share, compared to $0.7 million, or $0.03 per diluted share, in the prior year period. Adjusted EBITDA reached $2.1 million, improving from a loss of $(1.5) million in Q1 fiscal 2025, though down from $3.4 million year-over-year. The company highlighted progress in its business transformation, including consolidation of operations and cost structure improvements.
PetMed Express (PETS) has announced its upcoming fiscal second quarter 2024 earnings conference call, scheduled for November 6, 2024, at 4:30 PM Eastern Time. The company will release its financial results for the quarter ended September 30, 2024, before the call. Management will host the call followed by a Q&A session. The call will be accessible via U.S. dial-in (877-407-0789) and international dial-in (201-689-8562). A replay will be available until November 20, 2024, through toll-free (844-512-2921) and international (412-317-6671) numbers with passcode 13748837.
PetMed Express, Inc. (Nasdaq: PETS) has appointed Robyn D'Elia as Chief Financial Officer, effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning, including 24 years at Bed Bath & Beyond where she served as CFO from 2018 to 2020. Most recently, she was CFO at Odeko, a privately held operations partner for independent coffee shops and cafes.
As CFO at PetMeds, D'Elia will oversee the entire finance organization and report directly to President and CEO Sandra Campos. The company expects her expertise in financial discipline, operational rigor, and scaling organizations to be valuable as they expand and aim to deliver long-term value for shareholders, customers, and employees.
PetMed Express (Nasdaq: PETS), parent company of PetCareRx, announces its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The event is scheduled for September 4-6, 2024 in New York. Sandra Campos, CEO and President of PetMeds, will engage in a fireside chat on September 6, 2024, at 7:45 a.m. (Eastern Time).
Investors and interested parties can access a live audio webcast of the fireside chat through the 'Events & Presentations' section of PetMed's investor relations website. Following the event, a replay will be available for approximately 90 days on the same platform.
PetMed Express, Inc. (NASDAQ: PETS) reported its fiscal 2025 first quarter financial results. Net sales decreased by 13% to $68 million compared to the prior year quarter. However, the company achieved a net income of $3.8 million, or $0.18 diluted earnings per share, compared to a net loss in the previous year. This improvement was primarily due to a $8.7 million reversal of accumulated stock compensation expense associated with the former CEO's departure. The company's Adj. EBITDA was $(1.5) million, $4.9 million lower than the prior year quarter.
CEO Sandra Campos emphasized that Q1 FY'25 was a transition quarter, with new leadership focusing on cost reduction initiatives and customer growth strategies. The company is working on combining operations between PetMeds and PetCareRx, and early positive signs are validating their strategy to create an ecosystem of products and services for pets' well-being.
PetMed Express, Inc. (Nasdaq: PETS) has appointed Doug Krulik as Chief Accounting Officer (CAO), effective August 19, 2024. Krulik brings over 20 years of leadership experience in finance and accounting, most recently serving as Vice President Finance and Controller at Etherio Holdings. In this newly created role, he will oversee all aspects of PetMeds' accounting functions, including financial reporting, treasury, tax, compliance, and internal controls.
Krulik will report directly to the Office of the Chief Financial Officer. The appointment aligns with PetMeds' initiatives to enhance operational excellence and strengthen financial governance. CEO Sandra Campos expressed enthusiasm about Krulik's deep accounting expertise and his potential contribution to the company's growth journey.
PetMed Express, Inc. (Nasdaq: PETS), operating as PetMeds and parent company of PetCareRx, has announced its upcoming fiscal first quarter 2025 earnings call. The conference call is scheduled for Tuesday, August 6, 2024, at 4:30pm Eastern time. PETS management will host the call, which will be followed by a question-and-answer session.
Financial results for the quarter ended June 30, 2024, will be released via press release prior to the call. Investors can access the call using the U.S. dial-in number 844-826-3035 or the international number 412-317-5195. A webcast will also be available. For those unable to attend, a telephonic replay will be accessible until August 20, 2024.
FAQ
What is the current stock price of PetMed Express (PETS)?
What is the market cap of PetMed Express (PETS)?
What does PetMed Express, Inc. do?
Where can I buy PetMeds products?
What recent partnerships has PetMeds announced?
What is the significance of PetMeds’ partnership with Hill's Pet Nutrition?
Does PetMeds offer pet insurance?
What other services does PetMeds provide?
Who are PetMeds' primary customers?
When is PetMeds' next conference call?
How can I contact PetMeds for investor relations?
What is PetCareRx?
